Comments by "sdrc92126" (@sdrc92126) on "Ivermectin Concerns" video.

  1. "Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19." Jerusalem Post MAAYAN JAFFE-HOFFMAN AUGUST 2, 2021
    4